New Update on Medical Cannabis from the Legislative


A fraternal twin of Chase, Charlotte Figi was born as a healthy and normal child. But at the age of 3 months, her eyes had started to flicker soon after her routine nightly bath, informed the father of the child, Matt to CNN’s documentary correspondent, Sanjay Gupta which was aired on the August 7, 2013.

Physicians then gradually diagnosed the child with an extremely uncommon critical type of epilepsy called Dravet Syndrome. This usually causes it’s victims to die young. Residents of Colorado, the Figis tried out various kinds of treatments which included dosages of strong drugs like phenobarbital to Valium and other treatments like special diets and acupuncture of which none worked.

It was seen though that, there was some visible relief felt only by tiny doses of cannabidiol (oil extract from cannabis ) which is also called CBD oil that happens to be an active ingredient that is present in marijuana. Josh Harkins, the senator of the state Mississippi stated that a constituent where a 20 months old child suffered from Dravel syndrome and watched the documentary on CNN, made an attempt to reach out to him in order to help.

Harkins actually tried to make a change in the law since the law in the state of Mississippi does not clearly draw a line of differentiation between recreational use and medicinal use of marijuana. Experts inform that there are 3 main ingredients present in cannabis seeds, cannabidiol, THC and tetrahydrocannabinol. The chemical that gets the users of marijuana high is the called psychoactive.

On the other hand, cannabidiol had zero presence of psychoactive characteristics which curbs the brain’s chemical activity and electric activity with might later on result in a seizure.

The Senate Bill of Harkins; 2745 was redone in the list of schedule I of the state which hold control over low use of cannabidiol. This latest measure which was taken up by the Senate’s Drug policy committee and the Judiciary B which has no mention in the Schedule 1 statement says, “processed cannabis plant extract, oil or resin that contains more than fifteen percent (15 percent) of cannabidiol and no more than one-half of one percent (0.5 percent) of tetrahydrocannabinol if the preparation does not contain recognizable seed or leaf matter.”

The SB 2745 law, which was unanimously passed, has now gone to the Senate floor in order to be debated upon.

Leave a Reply

Your email address will not be published. Required fields are marked *